Works by Kettenberger, Hubert


Results: 18
    1

    Procollagen-lysine 2-oxoglutarate 5-dioxygenases are responsible for 5R-hydroxylysine modification of therapeutic T-cell bispecific monoclonal antibodies produced by Chinese hamster ovary cells.

    Published in:
    Frontiers in Bioengineering & Biotechnology, 2024, p. 1, doi. 10.3389/fbioe.2024.1414408
    By:
    • Bauer, Niels;
    • Boettger, Marco;
    • Papadaki, Styliani;
    • Leitner, Tanja;
    • Klostermann, Stefan;
    • Kettenberger, Hubert;
    • Georges, Guy;
    • Larraillet, Vincent;
    • Gluhacevic von Kruechten, Dino;
    • Hillringhaus, Lars;
    • Vogt, Annette;
    • Ausländer, Simon;
    • Popp, Oliver
    Publication type:
    Article
    2
    3
    4

    Assessing developability early in the discovery process for novel biologics.

    Published in:
    mAbs (1942-0862), 2023, v. 15, n. 1, p. 1, doi. 10.1080/19420862.2023.2171248
    By:
    • Fernández-Quintero, Monica L.;
    • Ljungars, Anne;
    • Waibl, Franz;
    • Greiff, Victor;
    • Andersen, Jan Terje;
    • Gjølberg, Torleif T.;
    • Jenkins, Timothy P.;
    • Voldborg, Bjørn Gunnar;
    • Grav, Lise Marie;
    • Kumar, Sandeep;
    • Georges, Guy;
    • Kettenberger, Hubert;
    • Liedl, Klaus R.;
    • Tessier, Peter M.;
    • McCafferty, John;
    • Laustsen, Andreas H.
    Publication type:
    Article
    5
    6
    7

    DuoMab: a novel CrossMab-based IgG-derived antibody format for enhanced antibody-dependent cell-mediated cytotoxicity.

    Published in:
    2019
    By:
    • Sustmann, Claudio;
    • Dickopf, Steffen;
    • Regula, Jörg T.;
    • Kettenberger, Hubert;
    • Mølhøj, Michael;
    • Gassner, Christian;
    • Weininger, Diana;
    • Fenn, Sebastian;
    • Manigold, Tobias;
    • Kling, Lothar;
    • Künkele, Klaus-Peter;
    • Schwaiger, Manfred;
    • Bossenmaier, Birgit;
    • Griese, Julia J.;
    • Hopfner, Karl-Peter;
    • Graff-Meyer, Alexandra;
    • Stahlberg, Henning;
    • Ringler, Philippe;
    • Lauer, Matthias E.;
    • Brinkmann, Ulrich
    Publication type:
    Report
    8

    XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer.

    Published in:
    mAbs (1942-0862), 2016, v. 8, n. 4, p. 811, doi. 10.1080/19420862.2016.1160989
    By:
    • Schanzer, Juergen M.;
    • Wartha, Katharina;
    • Moessner, Ekkehard;
    • Hosse, Ralf J.;
    • Moser, Samuel;
    • Croasdale, Rebecca;
    • Trochanowska, Halina;
    • Shao, Cuiying;
    • Wang, Peng;
    • Shi, Lei;
    • Weinzierl, Tina;
    • Rieder, Natascha;
    • Bacac, Marina;
    • Ries, Carola H.;
    • Kettenberger, Hubert;
    • Schlothauer, Tilman;
    • Friess, Thomas;
    • Umana, Pablo;
    • Klein, Christian
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18